What To Buy Based On The Biotech Pullback
By Jason Napodano, CFA
The IBB is down 16% from its highs. That’s probably not the bottom, but it does still represent a nice buying opportunity for long-term investors.
I look for stocks with at least 12 months cash, clean capital structures, credible management, near-term catalysts, and charismatic technology.
In my article I highlight some names that I either currently own or am thinking of buying based on this “bio-bear” market.
Please read the article on Seeking-Alpha:
More here –
What To Buy Based On The Biotech Pullback
See which stocks are being affected by Social Media
